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While HIV-1 infection of target cells with cell-free viral particles has been largely 
documented, intercellular transmission through direct cell-to-cell contact may be a 
predominant mode of propagation in host. To spread, HIV-1 infects cells of the immune 
system and takes advantage of their specific particularities and functions. Subversion 
of intercellular communication allows to improve HIV-1 replication through a multiplicity 
of intercellular structures and membrane protrusions, like tunneling nanotubes, filopo-
dia, or lamellipodia-like structures involved in the formation of the virological synapse. 
Other features of immune cells, like the immunological synapse or the phagocytosis of 
infected cells are hijacked by HIV-1 and used as gateways to infect target cells. Finally, 
HIV-1 reuses its fusogenic capacity to provoke fusion between infected donor cells 
and target cells, and to form infected syncytia with high capacity of viral production 
and improved capacities of motility or survival. All these modes of cell-to-cell transfer 
are now considered as viral mechanisms to escape immune system and antiretroviral 
therapies, and could be involved in the establishment of persistent virus reservoirs in 
different host tissues.
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CeLL-FRee AND CeLL-TO-CeLL iNFeCTiON
The worldwide pandemic of HIV-1 infection is a global and major public health problem, and sexual 
transmission is the major route of infection of the newly HIV-1-infected adults. Even though the 
use of antiretroviral therapies led to a net decrease of morbidity and mortality of HIV-1-infected 
patients, a better understanding of the cellular mechanisms involved in the sexual transmission 
and early dissemination of the virus is still required in order to rationally design more specific 
and potent strategies for HIV-1 prevention. A research priority for HIV-1 eradication is then the 
elucidation of the events involved in the mucosal viral transmission through the mucosa of the male 
and female rectal and genital tracts. While both cell-free and cell-associated HIV-1 are present in 
the semen, vaginal secretions, and anal mucus, and are thought to contribute to the virus sexual 
transmission, the cell-associated HIV-1 mucosal transmission has been largely understudied. 
Cell-to-cell transmission of HIV-1 involves various cell types of the immune system, including 
T lymphocytes, macrophages, and dendritic cells (DCs). Whereas the infection of T lymphocytes 
via cell-to-cell transfer was broadly investigated in  vitro, there is a paucity in knowledge of the 
mechanisms that control infection and virus dissemination in macrophages and DCs by cell-to-cell 
transfer. Yet, macrophages and DCs play crucial roles in the physiopathology of infection, with mac-
rophages being involved in the establishment of persistent virus reservoirs in different host tissues 
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while DCs participate in the early stages of virus transmission 
and dissemination after primo-infection at the level of genital 
and rectal mucosa. Specific therapies blocking HIV-1 mucosal 
transmission to these target cells should therefore be designed.
While HIV-1 infection of target cells with cell-free viral par-
ticles has been largely documented, pioneer studies from early 
1990s showed that HIV-1 dissemination was largely increased 
through the establishment of direct cell-to-cell contacts between 
infected donor CD4+ T  cells and target T  cells [for review: 
Ref. (1)]. At least in vitro, cell-to-cell transfer of HIV-1 between 
T cells leads to a massive and very efficient infection that may be 
100–1,000-fold more efficient than infection carried out by cell-
free viral particles (1–5). The efficiency of cell-to-cell infection 
between CD4+ T cells has been related to a high-multiplicity of 
infection at the site of the cell–cell contact, probably leading to 
the integration, and accelerated viral gene expression of multiple 
proviruses in the target cell (6–10). While some reports suggest 
that cell-to-cell infection could be the main route of HIV-1 
infection in vivo (10, 11), the specific contribution of cell-free 
and cell-to-cell infection by HIV-1 in infected hosts is still a 
matter of debate. Using multiphoton intravital microscopy in 
HIV-1-infected “humanized” mice, Murooka et al. showed that 
HIV-1-infected T  cells establish interaction with surrounding 
cells and can even form syncytia with other lymph node-resident 
cells. The potency of infected T cells in lymph nodes to migrate 
may facilitate virus cell-to-cell transmission and spreading 
in  vivo (12). Interestingly, exposure of human or macaque 
mucosal explants to HIV-1- or SIV-infected cells, allows more 
efficient viral transmission and infection than cell-free viruses 
(13, 14), suggesting the potency of HIV-1- or SIV-infected T cells 
to transmit viruses and propagate infection in host tissues. The 
high efficiency of cell-to-cell infection was also proposed to be 
a mechanism for HIV-1 to escape to antiretroviral therapy and 
neutralizing antibodies (15) but these results are still controver-
sial and will be discussed below (4, 6, 16).
Different modes of infection through different cellular struc-
tures enabling close contacts between virus-donor cells and 
recipient target cells have been described over the past years for 
cell-to-cell transmission of HIV-1 in vitro. Intercellular transfer of 
viral material has been described mainly through establishment 
of the infectious or virological synapses, but also using membrane 
protrusions such as filopodia and tunneling nanotubes (TNTs), 
and cell fusion or cell engulfment processes. The implication of 
these different structures and processes for cell-to-cell transfer 
and dissemination of HIV will be discussed in this review.
NANOTUBeS, FiLOPODiA
The role of membrane protrusions in intercellular communica-
tions has been widely explored [for review: Ref. (17)]. A large 
diversity of membrane protrusions have been described, both 
in  vitro (18, 19) and in  vivo (20–22), and play important roles 
in the transmission of information between cells from different 
physiological systems, such as neurons (18, 23, 24), myeloid cells 
(25–29), or T cells (30).
Among the described membrane protrusions, two differ-
ent types of nanotubes have been reported, corresponding to 
close-ended nanotubes and open-ended nanotubes (also known 
as TNTs) (27, 31, 32). Intercellular communications involving 
TNTs were first observed in 2004 as F-actin-containing mem-
brane extensions able to connect distant cells during minutes to 
hours (18). TNTs are fragile and dynamic structures extended 
up to 100  µm in length with diameters ranging from 50 to 
200 nm, and are not attached to the substratum (18, 30). They 
can mediate and facilitate the transfer, between several cell types, 
of cytoplasmic, and plasma membrane molecules, Ca2+ (29, 33), 
cargos including vesicles derived from various organelles such 
as early endosomes, endoplasmic reticulum, Golgi complex, and 
lysosomes (24, 33, 34), and even bigger cellular organelles like 
mitochondria and endosome-related structures (18, 32), but also 
pathogens such as bacteria (28).
Several studies showed that HIV-1 utilizes TNT networks 
to move from one cell to another leading to virus cell-to-cell 
transfer (25, 30, 34, 35) (Figure  1A). The frequency of TNT 
formation is not affected by HIV-1 in T cells but these structures 
could allow rapid spread of virus between T  cells (30). Virus 
particles can thus be transferred by surfing along the surface of 
TNTs between T cells (30). Virus dissemination through TNTs 
was also reported between macrophages, in which HIV-1 par-
ticles can be transferred through intracellular vesicles derived 
from the endosomal reticulum or the Golgi apparatus (34, 35). 
Furthermore, in macrophages, HIV-1 increases the number of 
these intercellular structures to infect new cells (25). The HIV-1 
Nef auxiliary protein has been reported to be responsible for the 
formation of TNTs in the THP-1 macrophage-like cell line (36) 
as well as in primary monocyte-derived macrophages, in which 
Nef alters the localization of the scaffolding protein M-Sec (37), 
which is a key regulator of TNT formation by a still undefined 
mechanism (26).
Another route of viral cell-to-cell transmission through 
membrane extension involving formation of filopodia has 
been first described for transmission of the retroviral murine 
leukemia virus (MLV) (19). Filopodia are F-actin-rich thin 
plasma membrane extensions that are involved in several cellular 
functions, such as chemo-migration, adhesion to the extracel-
lular matrix, or formation of cell–cell contacts [for review: Ref. 
(38)]. In DCs, after engagement of the lectin DC-SIGN, HIV-1 
mediates the activation of the small GTPase CDC42 and the 
remodeling of actin cytoskeleton to promote filopodia extension 
that allows virus transmission to neighboring CD4+ T cells (39) 
(Figure 1B). By budding at the tip of filopodia in DCs, HIV-1 
could be able to tether concomitantly several neighboring CD4+ 
T cells, leading to viral transfer and infection of the target T cells 
(40) (Figure 1C).
THe viROLOGiCAL SYNAPSeS
The formation of the so-called virological synapse is the major 
and well-established route for viral cell-to-cell transmission, and 
was first described in the context of human T-lympho-tropic 
virus infection as a close and organized cell-to-cell contact struc-
ture between an infected donor cell and a target cell, enabling the 
transfer of viral material between the two cells (41) (Figure 1D). 
The virological synapse has been named after its homologies with 
FiGURe 1 | Intercellular structures and processes involved in cell-to-cell transmission of HIV-1. (A–G) Schemes represent the different pathways for HIV-1 cell-to-cell 
transfer between donor cells (in green) and target cells (in pink).
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the immunological synapse formed between antigen-presenting 
cells (APCs) and T  cells for antigen presentation. During the 
formation of the immunological synapse, binding of the T-cell 
receptor (TCR) to the MHC-peptide complex expressed at the 
surface of APCs ensures T-cell activation by transducing signals 
that cause transcriptional upregulation of numerous genes, 
polarized secretion of cytokines or cytotoxic granules, and 
cell-proliferation (42, 43). Microtubules and actin cytoskeleton, 
together with adhesion molecules (LFA-1 and its ligand ICAM-1), 
participate in the stabilization of the immunological synapse.
Whilst virus cell-to-cell transmission was defined, from the 
early 1990s, to be more efficient than cell-free virus infection 
(1, 44–46), the concept of “virological synapse” between HIV-1-
infected donor cells and target cells was defined by the group of 
Quentin Sattentau as a “cytoskeleton-dependent, stable adhesive 
junction, across which virus is transmitted by directed transfer” 
(47). The virological synapse shares several common features 
with the immunological synapse. Indeed, formation of both 
virological and immunological synapses involves the recruitment 
of receptors and cell adhesion molecules to an adhesive interface 
in an actin-dependent manner (48, 49). We focus here on the 
structure of the virological synapse established between a donor 
infected CD4+ T-cell and a CD4+ T-cell target which has been 
the best documented (48, 50, 51). The specific synapses formed 
between DCs or macrophages and target CD4+ T cells will be 
described below.
The virological synapse is a dynamic structure initiated by 
the recognition of the target T-cell surface receptor CD4 by 
the viral surface envelope glycoprotein gp120 expressed at the 
surface of the infected donor T cell (Figure 2). This interaction 
allows the recruitment of the viral Gag polyprotein precursor 
to the intercellular interface (52) and triggers the recruitment 
of co-receptors, CXCR4 or CCR5, adhesion molecules LFA-1, 
ICAM-1, and other cell surface proteins such as tetraspanins to 
the site of intercellular contact, for stabilization of the virological 
synapse and efficient viral transfer (48, 52, 53). The interaction 
between HIV-1 envelope glycoprotein and the receptor CD4 is 
the major determinant for virus transfer across the virological 
synapse (54). In addition to CD4, the implication of the co-
receptors CCR5 and CXCR4 has been investigated by several 
groups. Some initial studies suggested that the formation of the 
virological synapse could be independent of the co-receptor 
usage since the inhibition of these co-receptors did not affect 
the number of cellular conjugates between cells (55) or HIV-1 
transfer (4, 56). However, other reports showed that expression 
of these co-receptors was necessary for productive infection of 
the target cells downstream of the formation of the virological 
synapse (57–60). Therefore, the use of the co-receptor could 
be dispensable for the formation of the virological synapse but 
could be required for efficient infection of the target cell after 
viral transfer through the virological synapse.
Similarly, the role of the adhesion molecules LFA-1 and ICAM-1 
in the formation of the virological synapse was debated. Initially, 
interaction between LFA-1 and ICAM-1 has been proposed to 
stabilize the virological synapse for efficient viral transfer. Jolly 
et  al. first showed that antibodies against LFA-1 and ICAM-1 
were able to partially block viral transfer through the virological 
synapse (48, 52). However, the percentages of inhibition were 
FiGURe 2 | Models for HIV-1 entry downstream of the virological synapse. After budding and release from infected donor cells, HIV could be able to enter the target 
cells via two distinct pathways. (left) Entry through endocytic pathway: immature virions interact with the CD4 receptor at cell surface of target cell, are internalized 
by endocytosis, mature in endocytic compartments, and fuse with the luminal membrane of endosomes. (right) Fusion with plasma membrane: mature viruses are 
captured by CD4, at the surface of target cells, and directly fuse with plasma membrane for release of viral material in the cytoplasm of the target cells.
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very different depending on the antibody used (40–90% inhibi-
tion using LFA-1 antibodies and 30% inhibition with ICAM-1 
antibodies). The role of adhesion molecules for the formation of 
the virological synapse and virus transfer was then confirmed, 
showing a significant threefold inhibition in virus transfer using 
a Jurkat T-cell line lacking the α subunit of LFA-1 (61). However, a 
third group obtained opposite results showing that virus transfer 
through the virological synapse between T cells did not require 
LFA-1 binding to ICAM-1 (55). Using antibodies blocking adhe-
sion molecules such as LFA-1, ICAM-1, and ICAM-3 in MOLT 
or primary T cells, or 293 T cells lacking LFA-1, no inhibition 
of viral transfer through the virological synapse was observed in 
this study. The different assays used to analyze viral transfer and 
viral production could explain this divergence. In these studies, 
antibodies targeting different epitopes were used to block adhe-
sion molecules and could have differential effects on virological 
synapse formation and HIV-1 transfer. The discrepancy in the 
results obtained by several groups could also be explained by 
the different cell models used in these experiments. Indeed, the 
level of adhesion molecule expression (i.e., ICAMs and Integrins) 
largely differs from T-cell lines to primary T  cells (52, 55). 
To conclude, while the recruitment of adhesion molecules to the 
virological synapse is well established (52, 53), their specific role 
and requirement for cell-to-cell transmission of HIV-1 remains 
to be determined.
Finally, specific rearrangements of the cytoskeleton are 
required for the formation of the virological synapse and efficient 
viral transfer. Engagement of the CD4 receptor by the gp120 viral 
envelope glycoprotein triggers actin cytoskeleton remodeling 
and microtubule polarization toward the virological synapse 
(51). These cytoskeleton modifications are needed for polariza-
tion of the Gag precursor and envelope glycoproteins to the site 
of cell–cell contact (61, 62). By comparison, engagement of the 
TCR by MHC-antigen complex expressed at the surface of APC 
induces a polarization of the T cell toward the immunological 
synapse that triggers a cascade of intracellular signals leading to 
cytoskeleton remodeling, cytokine gene expression, proliferation, 
and execution of the T-cell effector functions. Similarly, polariza-
tion of the microtubule-organizing center (MTOC) of infected 
donor T cells toward the virological synapse has been observed 
in 30–60% of the conjugated formed with target T cells (54, 63, 
64). Viral envelope glycoproteins are also reoriented to the viro-
logical synapse through their interaction with an intracellular 
compartment associated with the polarized MTOC. This suggests 
an active role of the microtubule network in the recruitment of 
the viral envelope to the virological synapse (4, 53, 54, 59, 63). 
Electron microscopy analyses with tomography reconstruction 
revealed the polarization of organelles such as mitochondria, 
lysosomes at the site of cell–cell contact in around 75% of the 
virological synapse formed. The colocalization of viral material 
with secretory lysosomal compartments and the relocalization 
of these vesicular compartments toward the cell–cell interface 
indicates that HIV-1 could take advantage of intracellular traffic 
and secretory pathways to disseminate through the virological 
synapse (63). Some molecules involved in T-cell signaling also 
participate in cell-to-cell transmission of HIV-1. Accordingly, 
polarization of the cells can be mediated by ICAM-1/LFA-1 
signaling, which in addition to its effect on stabilizing virologi-
cal synapse formation, induces a ZAP70-dependant signaling 
pathway for cytoskeleton remodeling, T cells polarization, and 
efficient HIV-1 transfer at the virological synapse (53, 64). In 
target T  cells, CD4 engagement by viral gp120 induces phos-
phorylation of the T-cell specific Src kinase Lck allowing the 
recruitment of several TCR signaling molecules such as ZAP70, 
LAT, SLP76, or PLCγ in their active phosphorylated form. This 
unusual signaling does not trigger regular T-cell activation nor 
proliferation, but could induce a local depletion of F-actin at 
the center of the virological synapse that could facilitate viral 
transfer to target cells (54).
The first observation of the virological synapse by electron 
microscopy by Jolly et al. showed that mature HIV-1 particles 
were clustered in the synaptic space (48), but they did not show 
evidence of endocytosis of viral particles by target cells, sug-
gesting that mature viruses released from the donor T cells at 
the virological synapse space could fuse directly with the plasma 
membrane of the target T cells (48). Another group also observed 
HIV-1 particles in the synaptic space by electron microscopy, 
but suggested that these particles could be internalized by target 
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cells into trypsin-resistant large intracellular vesicles containing 
several virus particles. This internalization of viruses could occur 
using an actin-dependent mechanism through lamellipodia-like 
structures (56). Several groups confirmed that HIV-1 can be 
internalized by endocytosis at the virological synapse. Therefore, 
immature HIV-1 particles have been shown to be transferred 
across the virological synapse through dynamin- and clathrin-
dependent endocytosis leading to productive infection of the 
target T  cells (59, 65–67). After internalization, the HIV-1 
particles were found in intracellular compartments that co-
localized with the early-endosomal marker EEA1 but not with 
the lysosomal-associated membrane protein LAMP1, indicating 
that viruses are internalized in endosomal compartments but are 
not addressed to lysosomal degradation (68). In accordance with 
these results, Dale et al. demonstrated that after endocytosis of 
immature virions by the target T cells, the cleavage of the Gag 
polyprotein precursor by the viral protease induced the matu-
ration of the viral particle in some endosomal compartments 
(57). This cleavage restored the membrane fusion activity of the 
viral envelope and led to viral-cell membrane fusion into these 
endosomal compartments.
However, the group of Quentin Sattentau, who first described 
the formation of the virological synapse for HIV-1 cell-to-cell 
transfer, failed to observe endocytosis of viral particles at 
the virological synapse using confocal microscopy, electron 
microscopy, or electron microscopy coupled with tomography 
(47, 60). Puigdomenech et al. hypothesized that these differ-
ent results could be explained by the different experimental 
systems used and the use of primary T cells or immortalized 
T-cell lines (69). They suggest that these differences may be 
associated with the different kinetics of the fusion events 
observed between primary CD4+ T  cells and T-cell lines. 
Delayed fusion at the plasma membrane of the target cell may 
increase virus endocytosis in primary cells (Figure  2, left). 
In contrast, a rapid fusion at the cell membrane in T-cell lines 
may favor HIV-1 transmission without need for endocytosis 
(Figure 2, right). From this hypothesis, these authors suggest 
that endocytosis of virus particles is the main mechanism used 
by HIV-1 for cell-to-cell transfer and infection of primary 
CD4+ T  cells. Remarkable differences between virological 
synapses formed with Jurkat cells or primary CD4+ T  cells 
have been indeed reported (70). Scanning electron microscopy 
experiments revealed strong differences in spatial distribution 
of virions at the intercellular interface and important dif-
ferences in the architecture of the contacts between T  cells. 
These differences could be due to the increase deformability 
of primary T  cells compared with the immortalized Jurkat 
cells, and questioned the relevance of cell line models used so 
far for studying virological synapse formation and cell-to-cell 
transmission of HIV-1.
It is noteworthy to mention that cell-to-cell transfer of HIV-1 
between T cells is associated to an increase mortality of the target 
cells, when compared with cell-free infection of T  cells. First, 
the massive entry of viral particles into target cells across the 
virological synapse has been shown to be responsible for caspase-
1-mediated pyropoptosis of target T cells (71). In addition, while 
the formation of the virological synapse is triggered by gp120/
CD4 interaction, it has been reported that upon cell-to-cell 
contact, the gp41 transmembrane viral glycoprotein was able to 
trigger hemifusion but not fusion events responsible for rapid 
CD4+ T-cell death (72, 73).
viral Transfer and Resistance  
to Neutralizing Antibodies and 
Antiretroviral Drugs
Like some other viruses (Herpesviruses, poxviruses, and 
Hepatitis C virus), it has been proposed that HIV-1 could 
escape, at least partially, to neutralization by specific antibodies 
targeting the viral envelope when it is transferred across the 
virological synapse. Failure of inhibition of HIV-1 cell-to-cell 
infection by neutralizing antibodies was first suggested in 1995 
in a study showing that antibodies against the glycan V3-loop 
of gp120 were unable to block cell-to-cell viral transfer (74). 
However, after characterization of the virological synapse for 
HIV-1 cell-to-cell transfer in 2004, several different groups 
tried to elucidate the mechanisms of neutralizing antibody 
escape in the virological synapse-mediated viral transfer. 
There is a general agreement that the potency of neutralizing 
antibodies is reduced during cell-to-cell transmission compared 
with cell-free infection and that only a subset of neutralizing 
antibodies can efficiently inhibit cell-to-cell transmission 
(47, 56, 75–77). For example, it was reported that several spe-
cific anti-gp120 antibodies targeting the CD4 binding site lost 
considerable potency (10- to 100-fold decrease) when HIV-1 
was transferred by cell-to-cell transmission (75). Though some 
antibodies are still able to block cell-to-cell viral transmission 
at high concentration, VRC01, which is one of the most potent 
antibody for inhibition of cell-free infection, is particularly inef-
fective for blocking cell-to-cell viral transfer (75). While most 
anti-gp120-directed antibodies, and in particular those directed 
against the gp120 CD4 binding site displayed a reduced activity 
during viral cell-to-cell transmission, the same group reported 
that the T20 fusion inhibitor targeting the gp41 transmem-
brane glycoprotein as well as neutralizing antibodies directed 
against gp41 maintained their activity and were thus able to 
block both cell-free and cell-to-cell infection with the same 
efficiency. However, other groups showed that some anti-gp41 
neutralizing antibodies failed to inhibit cell-to-cell transmission 
(4, 56, 77). Globally, the efficiency of neutralizing antibodies for 
neutralization of the virological synape-mediated viral transfer 
is variable and some epitopes of the viral envelope glycoproteins 
seem more susceptible than others to neutralization of the viral 
cell-to-cell transfer between T cells.
Similarly, the activity of the T20 peptide entry inhibitor of 
the Env-mediated membrane fusion on HIV-1 transmission 
through the virological synapse is still a matter of debate, and 
a lot of contradictory results have been published regarding 
the effect of this inhibitor. Whereas it was initially reported 
that T20 was unable to block virological synapse-mediated 
viral transfer using flow cytometry analysis (4), Martin et al. 
then showed that cell-free and cell-to-cell infection across 
the virological synapse were equivalently susceptible to T20, 
using qPCR for detection of infection in the target T  cells 
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(60). These different results can be explained by the different 
experimental approaches used since the first study was look-
ing for viral transfer of viral material when the other study 
analyzed de novo synthesized viral DNA after viral transfer. 
We can hypothesize that the T20 fusion inhibitor does not 
affect viral transfer across the virological synapse, but inhibits 
HIV-1 infection in the target cell after the viral transfer medi-
ated through the virological synapse. The fusion inhibitors 
T20 and C34, targeting gp41, could also have no effect on 
capture and endocytosis of virus particles for viral cell-to-cell 
transfer, but would rather block subsequent viral fusion in the 
endosomal compartments leading to inhibition of productive 
infection (65).
While it is usually accepted that HIV-1 could escape or is 
less sensitive to the inhibitory activity of antiviral drugs used 
in clinic when T cells are infected by virus transfer through the 
virological synapse, only a few studies have reported rational 
analyses of the effects of antiretroviral drugs such as anti-pro-
tease or anti-reverse transcriptase inhibitors on viral cell-to-cell 
transfer. Some studies indeed reported that HIV-1 virological 
synapse-mediated infection and cell-free infection were simi-
larly inhibited by anti-protease drugs (15, 78). Regarding reverse 
transcriptase inhibitors, it seems that non-nucleoside-analog 
inhibitors of the reverse transcriptase could block virological 
synapse-mediated infection of T-cell targets (15, 78), whereas 
nucleoside-analog reverse transcriptase inhibitors (NRTI) were 
unable to do it. However, it was also reported that cell-to-cell 
infection was blocked efficiently when these NRTIs were used 
in combination even if the level of inhibition is lower than for 
cell-free infection (15, 78, 79). Usage of HIV-1 protease inhibi-
tors Lopinavir and Darunavir has been reported as an efficient 
way to inhibit cell-to-cell transmission as efficiently as cell-free 
infection (79). This effect of protease inhibitors compared with 
reverse transcriptase inhibitors is suspected to be due to their 
ability to target immature virions and blocking their maturation 
in fully infectious viruses.
In conclusion, it seems from the data reported in the litera-
ture that the idea that the cell-to-cell viral transfer through the 
virological synapse can escape from neutralizing antibodies and 
antiretroviral drugs is not so evident and is probably depend-
ent on the inhibitors used. Further systematic investigations 
with standardized assays to evaluate and compare activities of 
neutralizing antibodies and antiretroviral drugs in both cell-free 
and cell-to-cell infections are absolutely needed to address this 
important point.
HeTeROGeNeiTY OF THe viROLOGiCAL 
SYNAPSeS
HIV-1 transmission through the virological synapse established 
between an infected donor T cell and a recipient target T cell have 
been extensively studied. Nonetheless, DCs and macrophages 
can also transmit HIV-1 to target CD4+ T  cells through the 
formation of a related virological synapse (80–82). If virus 
cell-to-cell transfer between DCs and T cells, as well as between 
macrophages and T  cells, presents some similarities with the 
virological synapse observed between T cells, they also showed 
some specific differences.
The DC infectious Synapse
Regarding DCs as virus-donor cells, two types of cell-to-cell viral 
transfer and infection of T-cell targets have been proposed: in 
cis-infection, DCs are productively infected and can then trans-
fer viruses to CD4+ T cells, whereas in trans-infection, DCs are 
able to capture HIV-1 independently of CD4 and then transfer 
viruses to CD4+ T cells through the formation of the so-called 
“infectious synapse” (39, 83–85) (Figure 1E). HIV-1 cis-infection 
and trans-infection of CD4+ T target cells from DCs have been 
proposed to be mediated by distinct processes (86). However, 
because DCs highly express antiviral cellular restriction fac-
tors (APOBEC3G, TRIM5α, BST-2, and SAMHD-I), HIV-1 
replicates poorly in this cell type. That is probably the reason 
why most of the studies of cell-to-cell transmission of HIV-1 
from infected DCs to T cells developed cis-infection models of 
DCs using massive quantities of VSV-G-pseudotyped HIV-1 
particles to infect DCs in vitro, thus questioning the validity of 
these models of cis-infection.
Regarding the trans-infection cell-to-cell process from DCs, 
several studies showed that DCs can capture HIV-1 through 
binding of the viral envelope glycoproteins to the mannose 
specific C-type lectin receptor (DC-SIGN) and store viruses 
into tetraspanin-enriched compartments, in continuity with the 
plasma membrane without viral replication in recipient DCs 
(58, 83, 84, 87). More recently, it has been reported that the 
immunoglobulin(I)-type lectin Siglec-1 (or CD169) can also 
bind to HIV-1 particles carrying sialyl-lactose gangliosides on 
their envelope (88–90). After capture, viruses remain at the cell 
surface or are internalized in vesicular containing compartments 
(see below). Then, DCs are able to transfer these viruses to CD4+ 
T cells independently of viral replication through the formation 
of an “infectious” synapse (91–94), thus decreasing the efficiency 
of broadly neutralizing antibodies on HIV-1 infection of target 
T cells (95).
While the formation of the virological synapse depends on 
the interaction between the viral gp120 envelope glycoprotein 
and the CD4 receptor, the infectious synapse formed during 
trans-infection does not rely upon CD4/gp120 interaction 
since Rodriguez-Plata et al. showed that the number of cell-
to-cell conjugates formed between DCs and CD4+ T cells was 
not increased in the presence of HIV-1 (85). However, they 
also reported that the formation of the infectious synapse 
was decreased by 60% when the interaction between the adhe-
sion molecules ICAM-1 and LFA-1 was disrupted. Further-
more, recognition of MHC-superantigen complexes presented 
at the surface of DCs by the TCR significantly enhanced virus 
transfer across the infectious synapse (85, 91). These authors 
suggest that the formation of the infectious synapse is not 
triggered by the virus but is more related to a hijacking of the 
immunological synapse by HIV-1. However, their experiments 
do not prove formally the formation of a canonical immuno-
logical synapse in their system as TCR or signaling molecules 
recruitment at the interface was not verified. Moreover, a pre-
vious study failed to detect any MHC-II or TCR recruitment at 
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the interface between DCs carrying viruses and target CD4+ 
T cells, thus excluding the identification of this structure as a 
bone fide immunological synapse (87).
While the formation of the infectious synapse does not rely 
on CD4/gp120 interaction, this interaction is still required for 
efficient productive infection of CD4+ T cells following forma-
tion of cell-to-cell conjugates with DCs carrying HIV-1. After 
the formation of conjugates, the CD4 receptor and CXCR4 
or CCR5 co-receptors are recruited at the site of the cell–cell 
contact (96). Furthermore, intercellular transfer to CD4+ T cells 
of virus particles captured by DCs can be blocked using high 
concentrations of broadly neutralizing antibodies targeting the 
gp120 and gp41 envelope glycoproteins (97).
Rearrangements of the actin cytoskeleton also play a key 
role in HIV-1 transfer across the infectious synapse. A recent 
screening shows that tetraspanin 7 and dynamin-2 control 
nucleation and cortical stabilization of actin to maintain viruses 
onto dendrites for efficient cell-to-cell transfer from DCs to 
CD4+ T  cells when cells are cocultured, and simultaneously 
infected with HIV-1 (98). Furthermore, it has been shown that 
large sheet-like membrane structures derived from DCs carrying 
HIV-1 wrap around T  cells leading to a large interface at the 
infectious synapse (58). Within this interface, filopodia exten-
sions from T cells are able to interact with the virus-containing 
compartments (VCCs) in continuity with the plasma membrane 
of DCs for efficient cell-to-cell transmission (58). Together, these 
results show that in DCs, HIV-1 can be efficiently transferred 
by hijacking the immunological synapse without productive 
infection of DCs.
As specialized DCs present in cervico-vaginal and rectal 
mucosa, Langerhans cells have been proposed to be the first 
targets of HIV-1 after sexual exposure. However, these cells 
were proposed to capture and degrade captured virions 
through expression of the DC-SIGN-related lectin Langerin 
at their surface, avoiding virus transmission from Langerhans 
cells to CD4+ T cells (99). More recently, in an ex vivo human 
tissue explant model, Ballweber et  al. showed that vaginal 
Langerhans cells were able to transmit HIV-1 to CD4+ T cells, 
without being pro ductively infected, rendering HIV-1 particles 
insensitive to inhibition by reverse transcriptase inhibitors in 
this context (100).
Of note, some studies suggest that the expression of Siglec-1 in 
macrophages mediates the internalization of HIV-1 particles in 
a VCC. As for DCs-to-T-cell transmission, the presence of these 
storage compartments in macrophages allows for the transfer 
of virions to CD4+ T  cells (3, 101). Interestingly, the role of 
Siglec-1 for viral capture by macrophages has been evidenced 
in vivo in lymph node from HIV-1 or MLV infected mice (90). 
By showing subsequent transfer of MLV from macrophages to 
B  cells, Sewald et  al. proposed that this mechanism could be 
transposed to HIV-1 macrophage-to-T-cell transmission (90).
Hiv-1 Transfer through Conjugates 
Formed with Macrophages
Compared with the cell-to-cell transmission mechanisms of 
HIV-1 involving T  cells or DCs as infected donor cells, little 
is known about the formation of conjugates between HIV-1-
infected macrophages and target CD4+ T  cells. As evidenced 
by the presence of infected macrophages in different tissues in 
infected patients, macrophages are cellular targets of HIV-1 
and probably play an important role in HIV-1 pathogenesis 
(102–108). Like other infected cells, they participate in cell-to-
cell transmission of HIV-1 and are essential for HIV-1 spread in 
tissues of infected patients. One major feature of HIV-1-infected 
macrophages is related to the assembly and budding steps of 
the new viral particles. While in T  cells viral assembly takes 
place at the plasma membrane, de novo formed viral particles 
accumulate both at the plasma membrane and in tetraspanin-
enriched compartments called VCCs in productively infected 
macrophages (109–112). These VCCs, which do not exhibit the 
same characteristics than endosomes or multivesicular bodies, 
but are characterized by the presence of the tetraspanins CD63 
and CD81 (113–116), and are connected to the extracellular 
space by thin channels in continuity with the plasma membrane 
(110, 117, 118). Viruses thus assemble in macrophages in a pro-
tected compartment and are then released in the extracellular 
environment.
Infected macrophages can efficiently transfer viruses to 
uninfected CD4+ T  cells across the formation of a virologi-
cal synapse but the mechanisms involved in the formation of 
this macrophage/T-cell virological synapse are not completely 
characterized (3, 119). During the formation of the conjugates 
between infected macrophages and target T cells, VCCs could 
rapidly move to the virological synapse (82) through an actin 
cytoskeleton-dependent mechanism (81). Similarly to the 
virological synapse formed between T  cells, the virological 
synapse involving virus-donor macrophages leads to the 
recruitment of CD4, CCR5, LFA-1, and ICAM-1, as well as 
the viral Gag precursor and envelope glycoproteins at the site 
of cell–cell contact (81, 119). In contrast to the virological 
synapse formed between T cells, which is dependent of CD4, 
the formation of conjugates between infected macrophages 
and CD4+ T  cells appears to be independent of gp120 (82), 
while the viral transfer is dependent of gp120/CD4 and 
LFA-1/ICAM-1 interactions (81). Through the formation of 
the virological synapse, infected macrophages can transfer 
a high multiplicity of HIV-1 to CD4+ T  cells, promoting 
reduced viral sensitivity to reverse transcriptase inhibitors as 
well as to a panel of neutralizing antibodies (81, 82). While the 
virological synapse between infected macrophage and T-cell 
targets show several differences with the virological synapse 
between T cells (82, 119, 120), no similar structure has been 
described so far, to our knowledge, between infected T cells 
and uninfected macrophages for virus cell-to-cell transfer in 
these HIV-1 target cells.
eNGULFMeNT OF iNFeCTeD T CeLLS  
BY MACROPHAGeS AND eNTOSiS
Despite the fact that HIV-1 infection of T cells by cell-to-cell 
transfer has been largely documented, cell-to-cell infection 
of macrophages remains poorly investigated. Recently, the 
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group of Quentin Sattentau pointed out for the first time a 
new mechanism of specific cell-to-cell transfer of HIV-1 
from infected CD4+ T  cells to macrophage targets (121) 
(Figure  1F). The authors showed that macrophages could 
engulf HIV-1-infected T cells leading to productive infection 
of the macrophage targets. The engulfment of infected healthy 
but rather dying T cells was significantly higher compared with 
uninfected healthy T cells, indicating that the cell death and 
infection of virus-donor T cells might independently promotes 
T-cell engulfment by macrophages. This preferential uptake 
of infected dying T  cells was independent of the interact ion 
between gp120 and the CD4 receptor but was dependent of 
remodeling of the actin cytoskeleton. Since this engulfment/
uptake of infected T  cells by macrophages was dependent 
of actin remodeling and was not inhibited by amiloride, an 
inhibitor of macropinocytosis, the authors suggested that 
this engulfment process likely results from phagocytosis 
mechanisms.
While the uptake of infected T  cell by macrophages was 
inde pendent of the Env/CD4 interaction, the productive 
infection of macrophages following uptake of T  cells would 
be dependent of this interaction, and also depended of the 
tropism of the viruses. The uptake of infected T cells was evi-
denced by a concentrated localization of the viral Gag precur-
sor in the macrophage target observed in association with the 
CD3 T-cell specific marker. The engulfment of T cells infected 
with CCR5-tropic viruses led to productive infection of the 
macrophage targets able to produce infectious virus particles 
in the cell-culture supernatant. In contrast, after engulfment 
of T cells infected with CXCR4-tropic viruses, no productive 
infection of the macrophage targets was observed (121). From 
these data, it appears evident that macrophages can be produc-
tively infected by phagocytosis of HIV-1-infected T cells, but 
the mechanisms for virus entry in macrophages from intracel-
lular phagocytosed T cells remains to be defined. Nonetheless, 
the dependency of co-receptor usage by HIV-1 particles for 
productive infection could indicate a fusion of viral particles 
with the phagosome membrane.
Phagocytosis of SIV-infected T cells by myeloid cells in vivo 
was also suggested by the group of Jason Brenchley in SIV-
infected macaque models (122, 123). Their studies point out 
the presence of viral RNA and DNA originating from T cells in 
myeloid cells from spleen and lymph nodes of infected monkeys, 
but do not formally prove that this presence of specific markers 
was related to a phagocytosis mechanism of SIV-infected T cells 
by myeloid cells, since no per  se phagocytosis experiment was 
carried out in these studies.
Of note, another type of engulfment of HIV-1-infected 
CD4+ T cells by epithelial cells via an entosis mechanism has 
been observed. Entosis refers to the invasion of non-apoptotic 
cells into another live cell and then induces the formation of 
cell-in-cell structures (124, 125). Using infected cells from an 
immortalized T-cell line, Ni et al. reported that epithelial cells 
could internalize infected T cells in vitro, as well as in vivo in 
sigmoid colon explants from HIV-1-infected patients showing 
the formation of cell-in-cell structures (126). Through this ento-
sis process, the epithelial cells could be productively infected, as 
evidenced by the diffuse intracytoplasmic staining of the viral 
capsid protein.
CeLL–CeLL FUSiON
Formation of T-Cell Syncytia
Cell-to-cell fusion between infected CD4+ T  cells, or between 
infected and uninfected CD4+ T cells, has been initially proposed 
to be another mechanism for HIV-1 infection and dissemination 
between T cells (127–131). Early studies suggested that infected 
T cells could fuse with uninfected T cells to form giant syncy-
tia, 5–100 times bigger than individual cells (131, 132). In this 
context, cell-to-cell fusion occurs through actin cytoskeleton 
rearrangements, is dependent of LFA-1/ICAM-1 interaction and 
is mediated through interaction between envelope glycoproteins 
expressed at the cell surface of infected cells and CD4 expressed 
on the target cells (127, 129, 131, 133). Yet, these T-cell syncy-
tia, initially observed only in  vitro with infected immortalized 
T-cell lines, have been shown to die rapidly by a mitochondrion-
dependent apoptosis mechanism (134, 135). The formation of 
HIV-1 T cell syncytia leads to activation of the serine-threonine 
kinase, mTOR, which mediates phosphorylation of the tran-
scription factor p53. Thus, p53 induces upregulation of the pro- 
apoptotic regulator Bax leading to mitochondrial permeabi-
lization and release of pro-apoptotic mitochondrial proteins 
(136, 137). Several groups thus proposed that this cytopathic 
effect related to the formation of T-cell syncytia could be the 
mechanism of the CD4+ T cells loss observed during infection 
in HIV-1-infected patients (127, 128, 132).
However, formation of T-cell syncytia has been a controversial 
subject since other studies did not observed formation of T-cell 
syncytia using HIV-1-infected primary CD4+ T cells (3, 4, 11). 
Because no evidence of the formation of such T-cell syncytia was 
reported in vivo, it has been suggested that these giant syncytia 
could be in vitro artifacts only observed with immortalized cell 
lines and restricted to CXCR4-viruses (138). Viral strains were 
indeed initially classified as syncytia-inducing or non-syncytia 
inducing (NSI) strains, referring to their capacity to induce 
syncytia in vitro, and then to their ability to use either CXCR4 or 
CCR5 for virus entry, respectively (139). However, cells infected 
with NSI viruses can readily form syncytia with CCR5-positive 
cells, and a new classification of viral strains based on CXCR4 or 
CCR5-usage was adopted (140).
Interestingly, small T-cell syncytia, containing no more 
than five nuclei, have been then observed in  vivo in lymph 
nodes from HIV-1-infected patients (141). In addition, some 
more recent studies using HIV-1-infected “humanized mouse 
models” reported the presence of motile infected syncytia in 
lymph nodes, smaller than those observed in vitro (12). These 
motile small T-cell syncytia can establish tethering interac-
tions with uninfected T  cells that may facilitate cell-to-cell 
transmission through the formation of a virological synapse 
(12, 142). Interestingly, these interactions between infected 
small syncytia and uninfected T cells do not lead to cell-to-cell 
fusion suggesting that this mechanism of cell fusion is finely 
regulated (12).
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inhibition of T-Cell Fusion at the 
virological Synapse
The numerous studies describing the formation of conjugates 
between infected and uninfected T cells for viral transfer across 
the virological synapse do not present observations of cell–cell 
fusion between the virus-donor T  cells expressing the viral 
envelope glycoproteins and the target T  cells expressing the 
CD4 receptor and CXCR4 and CCR5 co-receptors, confirming 
that this process is finely regulated during the formation of the 
virological synapse between T cells.
Since HIV-1 is a highly fusogenic virus that is preferentially 
transmitted by direct contact between two cells, the mechanisms 
inhibiting the fusion between an infected cell and a target cell 
deserves to be questioned. Indeed, in most of the T  cell-to- 
T-cell transmission of HIV-1, a very few syncytia are observed 
compared with the formation of virological synapses (3, 4, 11). 
Moreover, large syncytia formed with T cells were characterized 
as rapid-dying cells (134, 136), which might indicate that HIV-1 
has developed some mechanisms to inhibit the formation of these 
large T-cell syncytia to survive in infected host. As usually, it was 
proposed that HIV-1 took advantage of the intracellular systems 
displayed by its host, and used molecular mechanism to inhibit 
cell–cell fusion.
For example, the CD81 tetraspanin membrane protein is 
recruited at the site of cell–cell contact during HIV-1 cell-
to-cell transmission and was proposed to be involved in the 
regulation of fusion (143). CD81 knockdown or inhibition 
with a specific antibody dramatically increased the capacity of 
infected T  cells to fuse with surrounding non-infected cells, 
indicating that CD81 is a negative regulator of T  cell–T  cell 
fusion during virological synapse formation. CD81 expression 
at the virological synapse seems to be regulated by the actin/
plasma membrane connector, ezrin. Accordingly, reduction of 
ezrin expression in T cells decreased the level of CD81 local-
ized at virological synapses, thus increasing cell–cell fusion 
between infected T cells (144). Other tetraspanin proteins such 
as CD9, CD63, or CD82, have been also studied for their role 
in HIV-1-mediated cell–cell fusion (144, 145). In addition, it 
has been shown that CD63 may interact with the CXCR4 co-
receptor and induces downregulation of CXCR4 expression at 
the cell surface, resulting in the inhibition of HIV-1 infection 
(146, 147). Like CD81, these molecules may act as regulators of 
cell fusion, but most of the experiments have been performed 
using HeLa or HEK293T non-lymphoid cell lines. Therefore, 
experiments need to be performed in more relevant cell 
models to precisely define the molecular requirement of these 
tetraspanins in the regulation of syncytia formation between 
HIV-1-infected T cells.
Presence of Multinucleated Giant Cells 
(MGCs) in infected Tissues
The mechanism of T-cell syncytia formation has been largely 
documented in  vitro and discussed for its in  vivo relevance. 
Nonetheless, processes of cell–cell fusion for HIV-1 infection 
and dissemination are not restricted to T cells. Some studies 
showed that infected multinucleated macrophages, as well 
as multinucleated DCs, could be found in different tissues 
in  vivo in HIV-1-infected patients (148, 149). The presence 
of HIV-1-infected multinucleated syncytia expressing specific 
DC markers was found at the surface of the nasopharyngeal 
tonsils of HIV-1-infected patients and reported 20 years ago 
(148). The same group reported that infected T  cells could 
fuse in vitro with skin-derived DCs (94), thus leading to multi-
nucleated cell formation between T cells and DCs. Similarly, 
multinucleated giant HIV-1-infected macrophages have been 
found in  vivo during infection in several different tissues, 
including lymph nodes, spleen, lungs, genital, and digestive 
tracts, and the central nervous system (CNS) (102–106, 108, 
148, 150–153). While several groups showed the presence of 
infected multinucleated macrophages in tissues, and more 
specifically in the brain of HIV-1-infected patients and SIV-
infected monkeys, the cellular and molecular mechanisms 
related to their formation remained poorly investigated, with 
only one in  vitro study demonstrating a role for the HIV-1 
auxiliary protein Nef in the formation of multinucleated 
macrophages (154).
We recently reported in vitro original results and proposed a 
model for the formation of HIV-1-infected MGCs related to a 
two-step cell–cell fusion process for HIV-1 cell-to-cell transfer 
from infected T  cells and viral dissemination in macrophage 
targets (155) (Figure  1G). First, a heterotypic fusion occurs 
between HIV-1-infected T  cells and macrophage targets for 
virus transfer. Then the newly formed lymphocyte/macrophage 
infected fused cells acquire the ability to fuse with surrounding 
uninfected macrophages for virus dissemination. As evidenced 
by cell imaging analyses, the first step is related to the establish-
ment of contacts with infected T cells leading to the fusion of the 
infected T cells with macrophages. This cell fusion, dependent 
of the viral envelope/CD4 receptor interaction and restricted 
to CCR5-tropic viral strains, has been evidenced by a massive 
and fast transfer of Gag + material, as well as the presence of 
specific T cells markers (CD3, CD2, and Lck) in the cytoplasm 
and at the plasma membrane of the macrophage targets. The 
newly formed lymphocyte/macrophage fused cells (LMFCs) are 
then able to fuse with surrounding uninfected macrophages. 
These two sequential cell fusion processes are dependent on 
the viral envelope and lead to the formation of highly virus-
productive MGCs that could survive for a long time in host 
tissues to produce infectious virus particles as shown in vivo in 
lymphoid organs and the CNS of HIV-1-infected patients and 
SIV-infected macaques (103, 106, 108, 152, 156). Similarly, the 
first step related to the initial T cell-to-macrophage fusion agrees 
with results showing that myeloid cells from lymphoid tissues of 
SIV-infected macaques contain T-cell markers and viral RNA 
and DNA originating from infected T cells (122, 123). This route 
of infection may be a major determinant in vivo for virus dis-
semination and establishment of macrophage virus reservoirs 
in host tissues.
CONCLUSiON
Since the HIV-1 discovery, a lot of works have been accom-
plished to decipher its life cycle, in order to counteract virus 
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transmission and dissemination. Counteraction of host defen-
ses is a major feature of HIV-1, since it is able to infect a large 
panel of immune cells and to largely decrease their effector 
functions. During the past years, several entry pathways for 
virus dissemination have been discovered but still need further 
investigations. While HIV-1 was initially suspected to enter 
its target cells only through fusion of viral particles with host 
T-cell membranes, it appears more and more evident that it 
can use a large diversity of cellular features to infect target 
cells, especially through direct cell-to-cell transmission by 
close contacts between an infected virus-donor cell and a 
target cell. Cell-to-cell transfer of HIV-1 indeed allows a mas-
sive release of viral material toward the target cell inducing 
a strong increase of viral infectivity, compared with infection 
with cell-free viruses. Depending on the infected donor cells 
as well as the target cell lineages, HIV-1 can take advantage 
of their specific physiology and features to infect its host. 
In T cell-to-T-cell transmission, HIV-1 provokes the formation 
of contacts, through Env–CD4 interactions, to allow a mas-
sive transfer of viruses between the two cells, thus improving 
its ability to enter the host cell. This intercellular structure, 
called virological synapse, is strongly similar to another but 
physiological one, the immunological synapse, indicating 
the HIV-1 ability to hijack T-cell pathways to spread. During 
trans-infection from DCs to target T cells, HIV-1 is even able 
to re-use at its advantage the interaction between APCs and 
T  cells to cross the intercellular space for infection of target 
T cells. Through the interface formed between donor and tar-
get cells, filopodia coming from target T cells penetrate some 
VCCs in donor DCs to capture virions.
Therefore, intercellular communication pathways seem to 
be a road of choice for HIV-1 spreading. By increasing the 
frequency of filopodia formation in host infected cells, HIV-1 
also enhances the surface of contacts of infected cells with the 
environment, thus improving its efficiency to be transferred to 
a non-infected neighboring target cell. In addition, HIV-1 can 
also create real bridges between cells, the so-called TNTs, which 
resemble to highways for virus transmission and dissemination. 
Moreover, when infected T  cells are engulfed by specialized-
phagocytic cells such macrophages, instead of being destroyed, 
HIV-1 is still able to infect the phagocyte.
Finally, HIV-1 uses its own ability to fuse with host cell 
membranes to provoke fusion between an infected donor cell 
and a target cell. By this way, HIV-1 is totally hidden form 
extracellular milieu since the sharing of the cytosol between the 
two cells appears to be sufficient for viral material dissemina-
tion and productive infection the new-formed fused cell able 
to produce new fully infectious virus particles. While fusion 
between T  cells has been observed since a long time but was 
controverted as an in  vitro artifact, more recent studies have 
pointed out the presence of small T-cell syncytia in vivo in lymph 
nodes from infected patients and proposed that these syncytia 
are fully able to transmit viral particles by cell-to-cell transfer to 
other cell targets. Multinucleated macrophages or DCs have also 
been observed in vivo in different tissues from HIV-1-infected 
patients, indicating the cell-to-cell fusogenicity of HIV-1 for 
different cell types. We have recently discovered a new mecha-
nism of cell fusion between HIV-1-infected T  cells and target 
macrophages. Heterotypic fusion between these cells appears, at 
least in vitro, to be a massive and very fast process allowing the 
formation of LMFCs that acquire the ability to fuse rapidly with 
neighboring non-infected macrophages, thus forming MGCs. 
The new-formed MGCs can survive for a long period in  vitro 
and are highly productive of fully infectious viral particles. This 
important process could explain the presence of MGCs observed 
in several tissues of infected patients. Because of their long-time 
survival capacity, infected MGCs could participate in virus dis-
semination and establishment of persistent virus reservoirs in 
host tissues.
To conclude, while cell-associated HIV-1 transmission is 
belie ved to contribute to sexual transmission or viral spreading 
as well as to the formation of latent virus reservoirs, only few 
studies address the importance of cell-to-cell transfer of HIV-1 
in vivo, and further investigations are needed to decipher the role 
of all the intercellular structures and processes described in vitro 
for pathogenesis in HIV-1-infected patients.
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